Chronic hepatitis C (Q38312): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed an Item
 
(7 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Doença hepática caracterizada por inflamação e fibrose hepáticas causadas por mais de 6 meses de infecção pelo vírus da hepatite C. Mesmo na fase de cirrose pode não haver sintomas. Caso contrário, as manifestações clínicas incluem fadiga e comprometimento da qualidade de vida, endurecimento da margem hepática e complicações da cirrose (atrofia muscular, ascite, esplenomegalia/hipertensão portal). A hepatite C crônica aumenta o risco de diabetes mellitus tipo 2 e de doenças cardiovasculares, que contribuem para o aumento da mortalidade por todas as causas. A transmissão ocorre por contaminação de sangue e fluidos corporais, raramente por transmissão sexual e da mãe para o bebê no momento do nascimento (transmissão vertical). A confirmação do diagnóstico é feita pela detecção do RNA do HCV na presença de um anti-HCV positivo no soro.
description / endescription / en
 
A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis C virus. Even at stage of cirrhosis there may be no symptoms. Otherwise, clinical features include fatigue and impaired quality of life, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension). Chronic hepatitis C increases the risks of type 2 diabetes mellitus and cardiovascular disease, which contribute to increased all-cause mortality. Transmission is by blood and body fluid contamination, rarely by sexual transmission and from mother to baby at the time of birth (vertical transmission). Confirmation of the diagnosis is by detection of HCV RNA in the presence of a positive anti-HCV in serum.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1615937473 / rank
 
Normal rank
Property / CURIE
 
CID11:1E51.1
Property / CURIE: CID11:1E51.1 / rank
 
Normal rank
Property / Canary Token
 
dki-india-1E51.1
Property / Canary Token: dki-india-1E51.1 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: B18.2 / rank
 
Normal rank

Latest revision as of 03:17, 13 August 2026

A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis C virus. Even at stage of cirrhosis there may be no symptoms. Otherwise, clinical features include fatigue and impaired quality of life, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension). Chronic hepatitis C increases the risks of type 2 diabetes mellitus and cardiovascular disease, which contribute to increased all-cause mortality. Transmission is by blood and body fluid contamination, rarely by sexual transmission and from mother to baby at the time of birth (vertical transmission). Confirmation of the diagnosis is by detection of HCV RNA in the presence of a positive anti-HCV in serum.
Language Label Description Also known as
default for all languages
1E51.1
    English
    Chronic hepatitis C
    A liver disease characterised by liver inflammation and fibrosis caused by more than 6 months of infection with the hepatitis C virus. Even at stage of cirrhosis there may be no symptoms. Otherwise, clinical features include fatigue and impaired quality of life, hard liver edge and complications of cirrhosis (muscle wasting, ascites, splenomegaly/portal hypertension). Chronic hepatitis C increases the risks of type 2 diabetes mellitus and cardiovascular disease, which contribute to increased all-cause mortality. Transmission is by blood and body fluid contamination, rarely by sexual transmission and from mother to baby at the time of birth (vertical transmission). Confirmation of the diagnosis is by detection of HCV RNA in the presence of a positive anti-HCV in serum.

      Statements

      CID11:1E51.1
      0 references
      dki-india-1E51.1
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references